awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34264302-8BCE5272-0F6D-4D4A-B312-60749A35A704
Q34264302-8BCE5272-0F6D-4D4A-B312-60749A35A704
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34264302-8BCE5272-0F6D-4D4A-B312-60749A35A704
Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort
P2860
Q34264302-8BCE5272-0F6D-4D4A-B312-60749A35A704
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34264302-8BCE5272-0F6D-4D4A-B312-60749A35A704
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cd11b3389c308f500d70c1daac3e9bfe3789957e
P2860
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide D